Dermapharm Stock price
Compare with Peer Group
AI Insights on Dermapharm
Insights
Is Dermapharm a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Dermapharm Stock Analysis
Analyst Opinions
9 Analysts have issued a Dermapharm forecast:
Analyst Opinions
9 Analysts have issued a Dermapharm forecast:
Don't miss a Thing! We will send you all news about Dermapharm directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Dermapharm Holding SE engages in the development, manufacture. and market of patent-free pharmaceutical products. The company also involves in in-house development, in-house production, and distribution of pharmaceuticals and other healthcare products. It offers its products through the following brands: Dekristol 20,000 I.E., bite away, Herpotherm, sikapur, Ampho-Moronal, Solacutan, Ciclocutan, Minoxicutan, Prednisolut, Dienovel, Lactofem, Finapil, Panthenol-Augensalbe JENAPHARM, and Suxilep. The company was founded in 1991 and is headquartered in Grunwald, Germany.
| Head office | Germany |
| CEO | Dr. Feldmeier |
| Employees | 3,503 |
| Founded | 1991 |
| Website | ir.dermapharm.de |


